Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression

Autor: Stuart L. Silverman, Miroslav Backonja, Richard Vissing, Pritha Bhadra Brown, Lynne Pauer, Andrew Clair, Jaren W. Landen, Joseph M. Scavone
Rok vydání: 2017
Předmět:
Zdroj: Pain Medicine. 19:419-428
ISSN: 1526-4637
1526-2375
DOI: 10.1093/pm/pnx091
Popis: Objective To evaluate the effect of baseline characteristics on the treatment response to pregabalin in fibromyalgia (FM) patients with depression. Design Post hoc analysis from a randomized, double-blind, placebo-controlled, two-way crossover study of pregabalin (300 or 450 mg/day, twice daily). Subjects A total of 193 FM patients taking an antidepressant for comorbid depression. Methods The effect of patient baseline characteristics on the treatment response to pregabalin vs placebo was assessed for the primary efficacy end point (mean pain score on an 11-point numeric rating scale). Variables were analyzed using a linear mixed effects model with sequence, period, and treatment as fixed factors, and subject within sequence and within subject error as random factors. Results Pregabalin significantly improved mean pain scores vs placebo irrespective of age, duration of FM, number of prior FM medications, depression diagnosis, shorter-term depression (
Databáze: OpenAIRE